Exploring the role of miRNAs in the diagnosis of MODY3

The expression level of miR-378a-5p significantly decreased in type 2 diabetes andMODY3 patients, while miR-200b-3p expression was significantly decreased only in MODY3 patients.Conclusion: Although further studies with larger numbers of patients are required, this study demonstrated that the expression levelsof miR-200b-3p and miR-378a-5p decrease in MODY3 patients and suggests that miR-200b-3p is an especially strong candidate to useclinically for selecting suspected MODY3 patients.

📌 3 Key Takeaways

🎯

Objective & Hypothesis:Background/aim: MODY3 associated with HNF1A is the most common form of MODY and is clinically misdiagnosed as type 1diabetes due to similar clinical symptoms.

📊

Key Findings & Data:This study aimed to analyze the role of HNF1A-regulated miRNAs as a biomarker in thediagnosis of MODY3.Materials and methods: MIN6 cells were transfected with the HNF1A cDNA expression vector for overexpression or with siRNAspecific to HNF1A to silence its expression.

💡

Conclusion & Impact:The expression level of miR-378a-5p significantly decreased in type 2 diabetes andMODY3 patients, while miR-200b-3p expression was significantly decreased only in MODY3 patients.Conclusion: Although further studies with larger numbers of patients are required, this study demonstrated that the expression levelsof miR-200b-3p and miR-378a-5p decrease in MODY3 patients and suggests that miR-200b-3p is an especially strong candidate to useclinically for selecting suspected MODY3 patients.

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

Background/aim: MODY3 associated with HNF1A is the most common form of MODY and is clinically misdiagnosed as type 1diabetes due to similar clinical symptoms. This study aimed to analyze the role of HNF1A-regulated miRNAs as a biomarker in thediagnosis of MODY3.Materials and methods: MIN6 cells were transfected with the HNF1A cDNA expression vector for overexpression or with siRNAspecific to HNF1A to silence its expression. The HNF1A-regulated miRNAs were determined by RNA-Seq of the total RNA extract.Expressions of the candidate miRNAs in blood samples of MODY3, type 1 diabetes, and type 2 diabetes patients and in healthy subjectswere compared statistically by Mann–Whitney U tests.Results: This study revealed the presence of 238 known HNF1A-regulated miRNAs in MIN6 cells. miR-129-1-3p, miR-200b-3p, andmiR-378a-5p were selected as candidate miRNAs. The expression level of miR-378a-5p significantly decreased in type 2 diabetes andMODY3 patients, while miR-200b-3p expression was significantly decreased only in MODY3 patients.Conclusion: Although further studies with larger numbers of patients are required, this study demonstrated that the expression levelsof miR-200b-3p and miR-378a-5p decrease in MODY3 patients and suggests that miR-200b-3p is an especially strong candidate to useclinically for selecting suspected MODY3 patients.

🔖

Cite This Article

SARĞIN, M., KARABAY, A., AMURAN, G. G., AYDIN, N., BALTACI, O. F., YILMAZ, T., ÇOLAKOĞLU, Ş., BERBER, E. (2022). Exploring the role of miRNAs in the diagnosis of MODY3. Turkish Journal of Medical Sciences, Cilt: 48 - Sayı: 3, 620–626. https://ajindex.com/articles/610334

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (11)

Yamagata K. Regulation of pancreatic β-cell by the HNF transcription network: lessons from maturity-onset diabetes of the young. Endocr J 2003; 50: 491-499.
Nammo T, Yagamata K, Hamaoka R, Zhu Q, Akiyama TE, Gonzalez FJ, Miyagawa J, Matsuzawa Y. Expression profile of MODY3/HNF-1α protein in the developing mouse pancreas. Diabetologia 2002; 45: 1142-1153.
Nammo T, Yagamata K, Tanaka T, Kodama T, Sladek FM, Fukuki K, Katsube F, Sato Y, Miyagawa J, Shimomura I. Expression of HNF-4α (MODY1), HNF-1β (MODY5), and HNF-1α (MODY3) proteins in the developing mouse pancreas. Gene Expr Patterns 2008; 8: 96-106.
Harries LW, Ellard S, Stride A, Morgan AG, Hattersley AT. Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes. Hum Mol Genet 2006; 15: 2216-2224.
Yang Q, Yagamata K, Fukuki K, Cao Y, Nammo T, Iwahashi H, Wang H, Matsumura I, Hanafusa T, Bucala R et al. Hepatocyte nuclear factor-1α modulates pancreatic beta-cell growth by regulating the expression of insulin-like growth factor-1 in INS-1 cells. Diabetes 2002; 51: 1785-1792.
Lee YH, Sauer B, Gonzalez FJ. Laron dwarfism and noninsulin- dependent diabetes mellitus in the Hnf-1α knockout mouse. Mol Cell Biol 1998; 18: 3059-3068.
Dukes ID, Sreenan S, Roe MW, Levisetti M, Zhou YP, Ostrega D, Bell GI, Pontoglio M, Yaniv M, Philipson I et al. Defective pancreatic beta-cell glycolytic signaling in hepatocyte nuclear factor-1 alpha-deficient mice. J Biol Chem 1998; 273: 24457- 24464. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-269.
Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, Macdonald PE, Pfeffer S, Tushcl T, Rajewsky N, Rorsman P et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004; 432: 226-230.
Baroukh N, Ravier MA, Loder MK, Hill EV, Bounacer A, Scharfmann R, Rutter GA, Van Obberghen E. MicroRNA- 124a regulates Foxa2 expression and intracellular signaling in pancreatic beta-cell lines. J Biol Chem 2007; 282: 19575-19588.
Tang X, Muniappan L, Tang G, Ozcan S. Identification of glucose- regulated miRNAs from pancreatic β-cells reveals a role for miR-30d in insulin transcription. RNA 2008; 15: 287- 293. Ma J, Wang J, Liu Y, Wang C, Duan D, Lu N, Wang K, Zhang L, Gu K, Chen S et